ADVERTISEMENT Stefan Oelrich, president of Bayer’s pharmaceutical division and newly appointed head of the EU’s pharmaceutical lobby EFPIA, pointed out…
Read More

ADVERTISEMENT Stefan Oelrich, president of Bayer’s pharmaceutical division and newly appointed head of the EU’s pharmaceutical lobby EFPIA, pointed out…
Read More
Hey folks, let’s talk about MiCAR compliance and how it’s shaking up the European crypto startup scene. The Markets in…
Read More
There’s a fact we can’t avoid: recently, more and more attention (and funding) has been flowing into the defence sector.…
Read More